Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.63 |
| ▸ | HDAC1 | Q13547 | 9/20 | 0.51 |
| ▸ | HDAC6 | Q9UBN7 | 6/20 | 0.51 |
| ▸ | HDAC2 | Q92769 | 5/20 | 0.51 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.51 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.51 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.51 |
| ▸ | HDAC9 | Q9UKV0 | 4/20 | 0.42 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.42 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.42 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.41 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.41 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.41 |
| ▸ | DRD1 | P21728 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11697719 | 0.89 | CYP2D6 (0.51) | CYP2D6CYP2C19HDAC1HDAC6HDAC2 | |
| SCHEMBL57491 | 0.87 | CYP2D6 (0.80) | CYP2D6CYP2C19HDAC1HDAC6HDAC2 | |
| SCHEMBL2132415 | 0.83 | CHRM2 (0.49) | CYP2D6CYP2C19HDAC1HDAC6HDAC2 | |
| SCHEMBL11698781 | 0.83 | CYP2D6 (0.50) | CYP2D6CYP2C19HDAC1HDAC6HDAC2 | |
| SCHEMBL31490354 | 0.80 | POLB (0.58) | CYP2D6CYP2C19CHRM2ADRA2AADRA2B | |
| SCHEMBL440638 | 0.80 | POLB (0.58) | CYP2D6CYP2C19CHRM2ADRA2AADRA2B | |
| Ethylene SCHEMBL28037648 | 0.80 | CHRM2 (0.46) | CYP2D6CYP2C19HDAC1HDAC6HDAC2 | |
| SCHEMBL31539931 | 0.79 | CYP2D6 (0.63) | CYP2D6CYP2C19HDAC1HDAC6HDAC2 | |
| SCHEMBL30143833 | 0.79 | CYP2D6 (0.69) | CYP2D6CYP2C19HDAC1HDAC6HDAC2 | |
| SCHEMBL229946 | 0.79 | CYP2D6 (0.69) | CYP2D6CYP2C19HDAC1HDAC6HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8859533-B2 | Metalloinsertor complexes targeted to DNA mismatches | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2014-10-14 | — | — | US | claimed |
| US-9051345-B2 | Metalloinsertor complexes targeted to DNA mismatches | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2015-06-09 | — | — | US | disclosed |
| WO-2014200497-A1 | METALLOINSERTOR COMPLEXES TARGETED TO DNA MISMATCHES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2014-12-18 | — | — | WO | disclosed |
| US-8859533-B2 | Metalloinsertor complexes targeted to DNA mismatches | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2014-10-14 | — | — | US | disclosed |
| EP-2707377-A2 | METALLOINSERTOR COMPLEXES TARGETED TO DNA MISMATCHES | California Institute of Technology (US) | 2014-03-19 | — | — | EP | disclosed |
| US-20130345189-A1 | METALLOINSERTOR COMPLEXES TARGETED TO DNA MISMATCHES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2013-12-26 | — | — | US | disclosed |
| US-20130090319-A1 | METALLOINSERTOR COMPLEXES TARGETED TO DNA MISMATCHES | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2013-04-11 | — | — | US | disclosed |
| WO-2012155004-A2 | METALLOINSERTOR COMPLEXES TARGETED TO DNA MISMATCHES | CALIFORNIA INSITUTE OF TECHNOLOGY (US) | 2012-11-15 | — | — | WO | disclosed |
| US-4063887-A | HYDROXYAMINE COMPOUND | CELANESE CORPORATION (US) | 1977-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130090319-A1 | METALLOINSERTOR COMPLEXES TARGETED TO DNA MISMATCHES | MSH2, MSH6, PMS2 | CYP2D6 2293/4885CYP2C19 3522/4885HDAC1 3701/4885 |
| US-20130345189-A1 | METALLOINSERTOR COMPLEXES TARGETED TO DNA MISMATCHES | MSH2, MSH6, PMS2 | CYP2D6 2293/4885CYP2C19 3522/4885HDAC1 3701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.